ibuprofen has been researched along with Acute Edematous Pancreatitis in 10 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
| Excerpt | Relevance | Reference |
|---|---|---|
| "Postprocedural pain scores and the number of patients who had increased abdominal pain after the procedure were significantly lower in the IV ibuprofen group." | 9.34 | IV Ibuprofen for Prevention of Post-ERCP Pancreatitis in Children: A Randomized Placebo-controlled Feasibility Study. ( Barth, BA; Gurram, B; Huang, R; Troendle, DM, 2020) |
| " The aim of the study was to explore the mechanism of ibuprofen alleviating myocardial injury caused by acute pancreatitis (AP)." | 8.12 | Ibuprofen Alleviates Acute Pancreatitis- (AP-) Induced Myocardial Injury by Inhibiting AIM2. ( Chen, K; Wang, S, 2022) |
| "This is a case report of a 16-year-old boy with possible drug-induced pancreatitis (DIP) caused by ibuprofen." | 7.81 | [Acute pancreatitis after ingestion of ibuprofen in a 16-year-old boy]. ( Bruusgaard-Mouritsen, ME; Hansen, MB; Leerhøy, B, 2015) |
| "We present a case of a young man with acute pancreatitis probably secondary to an ibuprofen overdose." | 7.73 | A case of probable ibuprofen-induced acute pancreatitis. ( Conlon, KC; Magill, P; Neary, P; Ridgway, PF, 2006) |
| "Postprocedural pain scores and the number of patients who had increased abdominal pain after the procedure were significantly lower in the IV ibuprofen group." | 5.34 | IV Ibuprofen for Prevention of Post-ERCP Pancreatitis in Children: A Randomized Placebo-controlled Feasibility Study. ( Barth, BA; Gurram, B; Huang, R; Troendle, DM, 2020) |
| " The aim of the study was to explore the mechanism of ibuprofen alleviating myocardial injury caused by acute pancreatitis (AP)." | 4.12 | Ibuprofen Alleviates Acute Pancreatitis- (AP-) Induced Myocardial Injury by Inhibiting AIM2. ( Chen, K; Wang, S, 2022) |
| "The NSAIDs ibuprofen and diclofenac were administered to C57BL/6 mice after induction of pancreatitis with serial injections of cerulein." | 3.88 | Ibuprofen and diclofenac treatments reduce proliferation of pancreatic acinar cells upon inflammatory injury and mitogenic stimulation. ( Bombardo, M; Chen, R; Graf, R; Malagola, E; Rudnicka, A; Sonda, S, 2018) |
| "This is a case report of a 16-year-old boy with possible drug-induced pancreatitis (DIP) caused by ibuprofen." | 3.81 | [Acute pancreatitis after ingestion of ibuprofen in a 16-year-old boy]. ( Bruusgaard-Mouritsen, ME; Hansen, MB; Leerhøy, B, 2015) |
| "We present a case of a young man with acute pancreatitis probably secondary to an ibuprofen overdose." | 3.73 | A case of probable ibuprofen-induced acute pancreatitis. ( Conlon, KC; Magill, P; Neary, P; Ridgway, PF, 2006) |
| "To study the role of the vasodilatory, antiaggregatory prostacyclin (PGI2) and its endogenous antagonist thromboxane A2 (TxA2) in acute pancreatitis, we measured serum thromboxane B2 (TxB2, which indicates platelet TxA2 production) and plasma 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha, which indicates systemic PGI2 production) from sequential blood samples in trypsin and taurocholate induced acute canine hemorrhagic pancreatitis (AHP)." | 3.67 | Prostacyclin and thromboxane in acute hemorrhagic pancreatitis in dogs. ( Jalovaara, P; Kairaluoma, M; Kiviniemi, H; Laitinen, S; Rämö, J; Ståhlberg, M; Viinikka, L, 1987) |
| "(1) hemorrhagic pancreatitis was associated with high levels of PGI2 in blood 15 times and in hemorrhagic ascitic fluid 25 times that of baseline; (2) steroids and ibuprofen blocked PGI2 production (p less than 0." | 3.67 | Effect of prostaglandin blockers on ascites fluid in pancreatitis. ( Farias, LR; Frey, CF; Gunther, R; Holcroft, JW, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K | 1 |
| Wang, S | 1 |
| Troendle, DM | 1 |
| Gurram, B | 1 |
| Huang, R | 1 |
| Barth, BA | 1 |
| Sato, N | 1 |
| Yako, Y | 1 |
| Maruyama, T | 1 |
| Ishikawa, S | 1 |
| Kuromiya, K | 1 |
| Tokuoka, SM | 1 |
| Kita, Y | 1 |
| Fujita, Y | 1 |
| Bombardo, M | 1 |
| Malagola, E | 1 |
| Chen, R | 1 |
| Rudnicka, A | 1 |
| Graf, R | 1 |
| Sonda, S | 1 |
| Yeomans, ND | 1 |
| Graham, DY | 1 |
| Wang, Q | 1 |
| Wolski, K | 1 |
| Borer, J | 1 |
| Husni, EM | 1 |
| Libby, P | 1 |
| Lincoff, MA | 1 |
| Lüscher, T | 1 |
| Wisniewski, LM | 1 |
| Bao, W | 1 |
| Walker, C | 1 |
| Nissen, SE | 1 |
| Bruusgaard-Mouritsen, ME | 1 |
| Leerhøy, B | 1 |
| Hansen, MB | 1 |
| Magill, P | 1 |
| Ridgway, PF | 1 |
| Conlon, KC | 1 |
| Neary, P | 1 |
| Kiviniemi, H | 1 |
| Rämö, J | 1 |
| Ståhlberg, M | 1 |
| Laitinen, S | 1 |
| Jalovaara, P | 1 |
| Viinikka, L | 1 |
| Kairaluoma, M | 1 |
| Farias, LR | 1 |
| Frey, CF | 1 |
| Holcroft, JW | 1 |
| Gunther, R | 1 |
| O'Brien, WM | 1 |
| Bagby, GF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| IV Ibuprofen for the Prevention of Post-ERCP Pancreatitis[NCT02241512] | Phase 2 | 69 participants (Actual) | Interventional | 2014-09-30 | Terminated (stopped due to lack of funding) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Pain score recorded 24-hrs after the ERCP was performed as recorded on a 10-point Likert pain scale (0= lowest value, no pain, 10=highest value, severe pain) (NCT02241512)
Timeframe: pre-procedural, 24 hours
| Intervention | score on a Likert pain scale (Mean) |
|---|---|
| Ibuprofen | 1.1 |
| Placebo | 3.1 |
Number of patients with increased pain scores after the procedure (NCT02241512)
Timeframe: pre-procedural, 24 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Ibuprofen | 1 |
| Placebo | 11 |
Number of patients who develop post-ERCP bleeding (NCT02241512)
Timeframe: 2 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Ibuprofen | 2 |
| Placebo | 0 |
Number of patients who develop post-ERCP pancreatitis (NCT02241512)
Timeframe: 2 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Ibuprofen | 2 |
| Placebo | 5 |
1 review available for ibuprofen and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
Rare adverse reactions to nonsteroidal antiinflammatory drugs (3).
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Aspirin; Chemical and Drug Induced Liver Injury; | 1985 |
1 trial available for ibuprofen and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
IV Ibuprofen for Prevention of Post-ERCP Pancreatitis in Children: A Randomized Placebo-controlled Feasibility Study.
Topics: Abdominal Pain; Administration, Intravenous; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Ch | 2020 |
8 other studies available for ibuprofen and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
Ibuprofen Alleviates Acute Pancreatitis- (AP-) Induced Myocardial Injury by Inhibiting AIM2.
Topics: Acute Disease; Animals; DNA-Binding Proteins; Ibuprofen; Pancreatitis; Rats; Tumor Necrosis Factor-a | 2022 |
The COX-2/PGE
Topics: Animals; Anticarcinogenic Agents; Cell Line, Transformed; Cell Transformation, Neoplastic; Ceruletid | 2020 |
Ibuprofen and diclofenac treatments reduce proliferation of pancreatic acinar cells upon inflammatory injury and mitogenic stimulation.
Topics: Acinar Cells; Animals; Cell Differentiation; Cell Proliferation; Ceruletide; Cytokines; Diclofenac; | 2018 |
Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trial.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Celecoxib; Humans; Ibuprofen; Naproxe | 2018 |
[Acute pancreatitis after ingestion of ibuprofen in a 16-year-old boy].
Topics: Adolescent; Humans; Ibuprofen; Male; Pancreatitis; Suicide, Attempted; Tomography, X-Ray Computed | 2015 |
A case of probable ibuprofen-induced acute pancreatitis.
Topics: Acute Disease; Adolescent; Drug Overdose; Humans; Ibuprofen; Male; Pancreatitis | 2006 |
Prostacyclin and thromboxane in acute hemorrhagic pancreatitis in dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Animals; Blood Pressure; Dogs; Epoprostenol; Hemorrhage | 1987 |
Effect of prostaglandin blockers on ascites fluid in pancreatitis.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Animals; Ascitic Fluid; Biological Assay; Electrolytes; | 1985 |